4. Selected Balance Sheet Information

Prepaid expenses and other current assets (in thousands)

	September 30, 2016		December 31, 2015
Intrexon prepaid research and development expenses	$	-	$	643
Prepaid clinical research organizations		2,175		8,329
Prepaid insurances		75		339
Other prepaid expenses		547		208
Other current assets		294		-

Total	$	3,091	$	9,519

The Intrexon prepaid research and development expenses are classified as a current asset. As of September 30, 2016 the Company had applied all the of the Intrexon prepaid research and development expenses to research and development expenses.

Prepaid clinical research organization expense is classified as a current asset. The Company makes payments to the clinical research organizations based on agreed upon terms that includes payments in advance of study services. The Company anticipates that the majority of the prepaid clinical research organization expenses will be applied to research and development expenses during the balance of 2016.

Property and equipment, net (in thousands)

	September 30, 2016		December 31, 2015
Computer and office equipment	$	389	$	346
Software		11		11
Leasehold improvements		373		242

		773		599
Less accumulated depreciation and amortization		(191)		(105)

Total	$	582	$	494

Accrued expenses (in thousands)

	September 30, 2016		December 31, 2015
Accrued manufacturing costs	$	191	$	-
Accrued vendor payments		341		133
Accrued clinical consulting services		935		164
Other accrued expenses		23		-

Total	$	1,490	$	297

Accrued employee benefits (in thousands)

	September 30, 2016		December 31, 2015
Accrued bonus expense	$	1,065	$	-
Accrued vacation expense		193		153
Other accrued employee benefits		83		124

Total	$	1,341	$	277